Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-bound paclitaxel vs docetaxel in advanced HNSCC
NCT04766827Phase 4Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
A Phase 4 trial of Paclitaxel Micelles for Injection in head and neck squamous cell carcinoma (HNSCC), sponsored by Tianjin Medical University Cancer Institute and Hospital. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT04766827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04766827.